today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a pivotal Phase 3 clinical trial, PRECISION-AF, to assess the safety and efficacy of GencaroTM (bucindolol hydrochloride) as a genetically-targeted treatment for atrial fibrillation (AF) in patients with a...
Biggest gapper today #ABIO $ABIO, fell right away at market open. Looks to be setting up some possible support, ill watch it tomorrow and the next few days to see if we can break back above the median. You can visit my youtube and watch my full video recap, link in the description!
What I like about ABIO as a swing play:
1. All moving avgs in alignment
2. Even with today's bearish candle, we still have a hook
3. We are still possibly coming out of oversold
4. The MACD is about to give a buy signal
5. They had positive news Feb 27
6. Traders love filling the gap from Feb 23
7. Needs to keep having higher highs and higher lows.